83521-93-1

Basic information

• Product Name: 4-(1,3-dimethylimidazolidin-2-yl)phenol
• Synonyms: 4-(1,3-dimethylimidazolidin-2-yl)phenol
• CAS NO: 83521-93-1
• Molecular Formula: C₁₁H₁₆N₂O
• Molecular Weight: 192.26
• Mol File: 83521-93-1.mol

Chemical Properties

• Boiling Point: 293.4°C at 760 mmHg
• Flash Point: 135.1°C
• Appearance: /
• Density: 1.108g/cm³
• Vapor Pressure: 0.000985mmHg at 25°C
• Refractive Index: 1.567
• CAS DataBase Reference: 4-(1,3-dimethylimidazolidin-2-yl)phenol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1,3-dimethylimidazolidin-2-yl)phenol(83521-93-1)
• EPA Substance Registry System: 4-(1,3-dimethylimidazolidin-2-yl)phenol(83521-93-1)

Safety Data

• Hazardous Substances Data: 83521-93-1(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H16N2O/c1-12-7-8-13(2)11(12)9-3-5-10(14)6-4-9/h3-6,11,14H,7-8H2,1-2H3

Upstream product

• 123-08-0 4-hydroxy-benzaldehyde 
• 110-70-3 N,N`-dimethylethylenediamine 

Downstream Products

• 1312466-17-3 ethyl 3-(4-benzyloxy-2-bromophenyl)-2-ethoxyoxirane-2-carboxylate 
• 1338067-80-3 ethyl 3-bromo-3-(4-benzyloxy-2-bromophenyl)-2-oxopropanoate 
• 1312466-18-4 C₂₇H₂₇BrO₈ 
• 1312466-19-5 ethyl 6-(3-hydroxypropoxy)-2-(4-(benzyloxy)-2-bromophenyl)-2,3-dihydro-3,4-dihydroxybenzofuran-3-carboxylate 
• 1312466-20-8 3-(ethoxycarbonyl)-6-(3-hydroxypropoxy)-2-(4-(benzyloxy)-2-bromophenyl)-2,3-dihydro-3-hydroxybenzofuran-4-yl 4-methylbenzenesulfonate 
• 1312466-21-9 6-(3-hydroxypropoxy)-2-(4-(benzyloxy)-2-bromophenyl)-2,3-dihydro-3-hydroxy-3-(hydroxymethyl)benzofuran-4-yl 4-methylbenzenesulfonate 
• 1312466-22-0 9-(3-hydroxypropoxy)-3-(benzyloxy)-6a,11a-dihydro-6a-hydroxy-6H-benzofuro[3,2-c]chromen-7-yl 4-methylbenzenesulfonate 
• 1312466-23-1 9-(3-hydroxypropoxy)-3-(benzyloxy)-6a,11a-dihydro-6H-benzofuro[3,2-c]chromen-6a-ol 
• 1312466-24-2 3-benzyloxy-6a,11a-dihydro-6H-benzofuro[3,2-c]chromen-6a,9-diol 
• 22532-60-1 2-bromo-4-hydroxybenzaldehyde 
• 227603-76-1 4-(benzyloxy)-2-bromobenzaldehyde 
• 90151-01-2 4-hydroxy-2-iodobenzaldehyde 

Relevant articles and documents

INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE - SYNTHESIS AND USE THEREOF FOR TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA

The present invention relates to new compounds of general formula I, their synthesis, their pharmaceutically acceptable salts, and their use in treatment of T-cell acute lymphoblastic leukemia and lymphoma.

Asymmetric total syntheses of (-)-variabilin and (-)-glycinol

Total syntheses of (-)-variabilin and (-)-glycinol have been accomplished, using the catalytic, asymmetric "interrupted" Feist-Benary reaction (IFB) as the key transformation to introduce both stereogenic centers. A monoquinidine pyrimidinyl ether catalyst affords the IFB products in over 90% ee in both cases. Other key steps include an intramolecular Buchwald-Hartwig coupling and a nickel-catalyzed aryl tosylate reduction.

NOVEL METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES

Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) are provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (I), either alone or as a part of combination therapy. Novel compounds of formula (I) are also provided for.

Comparative radioprotective activity of various pentagonal compounds with two heteroatomes

Various heterocyclic compounds with two heteroatomes were synthesized and their potential radioprotective activity was tested. This study shows the interest of phenylthiazolidines derivatives in chemical radioprotection.